Skip to main content
TheraVet SA logo

TheraVet SA — Investor Relations & Filings

Ticker · ALVET ISIN · BE0974387194 LEI · 984500804EBR3F1EFF71 BR Manufacturing
Open in API
Filings indexed 239 across all filing types
Latest filing 2025-03-07 Legal Proceedings Report
Country BE Belgium
Listing BR ALVET

About TheraVet SA

https://www.egeiro.com/

TheraVet SA is a veterinary biotechnology company specializing in the development and commercialization of treatments for osteoarticular diseases in companion animals. The company focuses on creating a portfolio of pharmaceutical products and solutions designed to manage bone and joint conditions, such as osteoarthritis. Its primary objective is to provide innovative therapeutic options to improve the mobility and quality of life for pets.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Legal Proceedings Report Classification · 99% confidence The document is a press release ('Communiqué de presse') dated March 7, 2025, announcing a critical corporate event: the Board of Directors' decision to file for bankruptcy ('faire aveu de faillite'). This decision is explicitly linked to the suspension of trading and issues surrounding a Reverse Take Over (RTO) attempt. This type of announcement, detailing a major corporate event that significantly impacts the company's existence or structure, does not fit neatly into standard periodic reports (10-K, IR, ER) or specific financial actions (CAP, DIV). While bankruptcy could potentially lead to a Legal Proceedings Report (LTR), the immediate nature of this announcement—a formal declaration of insolvency by the board—is best categorized as a significant regulatory/corporate event announcement. Since there is no specific code for 'Bankruptcy Announcement,' and it is a material, non-standard regulatory disclosure, the most appropriate fallback category is Regulatory Filings (RNS), as it is an 'INFORMATION REGLEMENTEE – INFORMATION PRIVILEGIEE' (Regulated Information – Privileged Information) that must be disclosed immediately.
2025-03-07 French
Informations privilégiées / Autres communiqués
Legal Proceedings Report Classification · 99% confidence The document is a press release ('Communiqué de presse') dated March 7, 2025, announcing a critical corporate event: the Board of Directors' decision to file for bankruptcy ('faire aveu de faillite'). This decision is explicitly linked to the suspension of trading and issues surrounding a Reverse Take Over (RTO) attempt. This type of announcement, detailing a major corporate event that significantly impacts the company's existence or structure, does not fit neatly into standard periodic reports (10-K, IR, ER) or specific financial actions (CAP, DIV). While bankruptcy could potentially lead to a Legal Proceedings Report (LTR), the immediate nature of this announcement—a formal declaration of insolvency by the board—is best categorized as a significant regulatory/corporate event announcement. Since there is no specific code for 'Bankruptcy Announcement,' and it is a material, non-standard regulatory disclosure, the most appropriate fallback category is Regulatory Filings (RNS), as it is an 'INFORMATION REGLEMENTEE – INFORMATION PRIVILEGIEE' (Regulated Information – Privileged Information) that must be disclosed immediately.
2025-03-07 French
20250307CA _EGEIRO CP eng.pdf
Legal Proceedings Report Classification · 100% confidence The document is a press release announcing the Board of Directors' decision to file for bankruptcy due to failed restructuring and regulatory issues (RTO reclassification). It does not fit into specific categories like 10-K, IR, or M&A, and it is not a report publication announcement. As it is a significant regulatory announcement regarding the company's status and financial viability, it falls under the general regulatory filings category.
2025-03-07 English
20250307 CA_EGEIRO CP.pdf
Legal Proceedings Report Classification · 100% confidence The document is a press release announcing that the Board of Directors of EGEIRO Pharma has decided to file for bankruptcy ('aveu de faillite'). It details the reasons behind this decision, including regulatory issues with Euronext and failed financial restructuring efforts. Since this is a significant regulatory announcement regarding the company's status and does not fit into specific categories like M&A, earnings, or governance, it falls under the general regulatory filing category.
2025-03-07 French
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release from EGEIRO Pharma announcing that Euronext has classified a recent asset contribution as a 'reverse takeover' (RTO). It details the regulatory implications of this classification, including the requirement to file for a new listing and the potential for delisting if requirements are not met. While it mentions a potential investment, the core subject is the regulatory classification of a corporate transaction (RTO) and its impact on the company's listing status. This fits best under 'Regulatory Filings' (RNS) as it is a general regulatory announcement regarding corporate status and exchange compliance.
2025-01-28 English
Informations privilégiées / Autres communiqués
M&A Activity Classification · 92% confidence The document is a press release from EGEIRO Pharma regarding a regulatory decision by Euronext to classify a specific asset contribution transaction as a 'Reverse TakeOver' (RTO). It discusses the implications for the company's listing status, the requirement to file a new admission document, and the suspension of trading. This is a regulatory announcement concerning the company's listing and corporate structure, which fits best under the 'Regulatory Filings' (RNS) category as it does not fall into specific categories like M&A (which usually refers to the deal itself rather than the regulatory classification of the listing) or Delisting (as it is a notice of a process to maintain listing).
2025-01-28 French

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.